WGS

GeneDx Holdings Corp. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-23

Figures on this page computed 2026-11-08 13:05 UTC

Last close

69.34USD

Market data, 2026-11-04

WGS: weekly closes from 139.73 on 2025-11-07 to 69.34 on 2026-11-04, a move of -50.4%. Prices in USD.

Weekly closes, 2025-11-07 to 2026-11-04

Over that span: -50.4%

Except where said otherwise: 10-K for 2025, filed 2026-02-23

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-23
The filing itself
-4.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
- 10-Q for 2025, filed 2026-08-03
- 10-K for 2025, filed 2026-02-23
- 10-Q for 2025, filed 2026-08-03
The filing itself
-4.9%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
The filing itself
3.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
The filing itself
0.37Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-Q for 2025, filed 2026-08-03
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.21 against 0.38 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.70x

0.11x

-0.11x

1.41x

0.59x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-23

Sales1.70x
Its own average over 7 years, 251.1M.
Profit0.11x
Its own average over 7 years, -187.8M.
Free cash flow-0.11x
Its own average over 7 years, -125.6M.
Debt1.41x
Its own average over 6 years, 80.2M.
Price0.59x
Its own average over 7 years, 117. Market data, 2026-11-04

Free cash flow is furthest from its own average, at -0.11 times.

The filed years, as a table

Each line is 100 at 2019-12-31, the first year we hold.

Filed year	Sales	Shares in issue
2019-12-31	100.0	100.0
2020-12-31	91.4	4,137.9
2021-12-31	108.2	87,159,225.0
2022-12-31	119.6	272,435,225.8
2023-12-31	103.3	647,012,610.5
2024-12-31	155.7	715,653,249.2
2025-12-31	217.9	762,239,695.2

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001818331-26-000015
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001818331-26-000015
Reported in: USD

The filing itself

Figures behind the shape

Growth

19.0%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate19.0%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income59.8%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

-4.1%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capital-4.1%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
- 10-Q for 2025, filed 2026-08-03
- 10-K for 2025, filed 2026-02-23
- 10-Q for 2025, filed 2026-08-03
The filing itself
Return on equity-6.8%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-Q for 2025, filed 2026-08-03
The filing itself
Return on assets-4.0%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-Q for 2025, filed 2026-08-03
The filing itself

Margins

69.7%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin69.7%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
The filing itself
Operating margin-3.1%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
The filing itself
Net margin-4.9%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
The filing itself
Free cash flow margin3.3%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
The filing itself

Price

5.8x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-23
The filing itself
Price to book5.8x10-Q for 2025, filed 2026-08-03
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001628280-26-051878
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-08-03
- computed
- 10-K for 2025, filed 2026-02-23
The filing itself
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
- 10-Q for 2025, filed 2026-08-03
- 10-K for 2025, filed 2026-02-23
The filing itself
Price to sales ratio4.2x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
The filing itself

Safety

0.37

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity0.37
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-Q for 2025, filed 2026-08-03
The filing itself
Current ratio2.4610-Q for 2025, filed 2026-08-03
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001628280-26-051878
Reported in
USD
- 10-Q for 2025, filed 2026-08-03
- 10-Q for 2025, filed 2026-08-03
The filing itself
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
The filing itself
Altman Z-Score2.40
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-02-23
- Computed from the 10-K for 2025, filed 2026-02-23
- Computed from the 10-K for 2025, filed 2026-02-23
- Computed from the 10-K for 2025, filed 2026-02-23
- Computed from the 10-K for 2025, filed 2026-02-23

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001818331-26-000015
Reported in
USD
- 10-K for 2025, filed 2026-02-23
- Computed from the 10-K for 2025, filed 2026-02-23
- 10-K for 2025, filed 2026-02-23
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.